Arcutis Biotherapeutics, Inc. ARQT Operating Income
Operating Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s operating income?
- Arcutis Biotherapeutics, Inc. (ARQT) reported operating income of -$9.09M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s operating income changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s operating income increased by 62.9% year-over-year, from -$24.53M to -$9.09M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s operating income?
- Over 3 years (2021 to 2024), Arcutis Biotherapeutics, Inc.'s operating income has grown at a -14.7% compound annual growth rate (CAGR), from -$206.53M to -$128.4M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.